Juglone

Juglone

SCHEMBL2720570

O=C1C=CC(=O)c2c(O)cccc21.O=S(O)O

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.85
CDC25B P30305 4/20 0.85
AURKA O14965 4/20 0.85
KDM4E B2RXH2 4/20 0.85
RECQL P46063 4/20 0.85
KMT2A Q03164 4/20 0.85
AURKB Q96GD4 3/20 0.85
ALDH1A1 P00352 3/20 0.85
HPGD P15428 3/20 0.85
ALOX15 P16050 3/20 0.85
MAPK1 P28482 3/20 0.85
HSD17B10 Q99714 3/20 0.85
TDP1 Q9NUW8 3/20 0.85
P4HB P07237 3/20 0.85
MEN1 O00255 3/20 0.85
TOP1 P11387 3/20 0.85
TRPA1 O75762 2/20 0.85
TP53 P04637 2/20 0.85
CYP3A4 P08684 2/20 0.85
CASP1 P29466 2/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Juglone SCHEMBL34185 0.92 MAPT (1.00) MAPTCDC25BAURKAKDM4ERECQL
Juglone SCHEMBL29500185 0.92 MAPT (1.00) MAPTCDC25BAURKAKDM4ERECQL
Juglone SCHEMBL9280529 0.92 MAPT (1.00) MAPTCDC25BAURKAKDM4ERECQL
Juglone SCHEMBL17888856 0.90 MAPT (0.96) MAPTCDC25BAURKAKDM4ERECQL
Juglone SCHEMBL14246054 0.88 MAPT (0.92) MAPTCDC25BAURKAKDM4ERECQL
Anthraquinone SCHEMBL14245036 0.85 MAPT (0.85) MAPTCDC25BAURKAKDM4ERECQL
Juglone SCHEMBL27828137 0.85 MAPT (0.85) MAPTCDC25BAURKAKDM4ERECQL
Juglone SCHEMBL9476381 0.85 MAPT (0.85) MAPTCDC25BAURKAKDM4ERECQL
Juglone SCHEMBL25330089 0.83 MAPT (0.81) MAPTCDC25BAURKAKDM4ERECQL
Juglone SCHEMBL11781111 0.83 MAPT (0.81) MAPTCDC25BAURKAKDM4ERECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2629765-B1 METHODS AND COMPOSITIONS FOR TREATING POX VIRUS INFECTIONS WITH AN 1,4-NAPHTHOQUINONE AS ACTIVE AGENT HÜGIN AMBROS (CH) 2016-07-06 EP claimed
US-20130224286-A1 METHODS AND COMPOSITIONS FOR TREATING POX VIRUS INFECTIONS HUEGIN AMBROS (CH) 2013-08-29 US claimed
EP-2629765-A1 METHODS AND COMPOSITIONS FOR TREATING POX VIRUS INFECTIONS WITH AN 1, 4 -NAPHTHOQUINONE AS ACTIVE AGENT Hügin, Ambros (CH) 2013-08-28 EP claimed
WO-2012052956-A1 METHODS AND COMPOSITIONS FOR TREATING POX VIRUS INFECTIONS WITH AN 1, 4 -NAPHTHOQUINONE AS ACTIVE AGENT HUEGIN AMBROS (CH) 2012-04-26 WO claimed
EP-2629765-B1 METHODS AND COMPOSITIONS FOR TREATING POX VIRUS INFECTIONS WITH AN 1,4-NAPHTHOQUINONE AS ACTIVE AGENT HÜGIN AMBROS (CH) 2016-07-06 EP disclosed
US-20130224286-A1 METHODS AND COMPOSITIONS FOR TREATING POX VIRUS INFECTIONS HUEGIN AMBROS (CH) 2013-08-29 US disclosed
EP-2629765-A1 METHODS AND COMPOSITIONS FOR TREATING POX VIRUS INFECTIONS WITH AN 1, 4 -NAPHTHOQUINONE AS ACTIVE AGENT Hügin, Ambros (CH) 2013-08-28 EP disclosed
WO-2012052956-A1 METHODS AND COMPOSITIONS FOR TREATING POX VIRUS INFECTIONS WITH AN 1, 4 -NAPHTHOQUINONE AS ACTIVE AGENT HUEGIN AMBROS (CH) 2012-04-26 WO disclosed